Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Rhein lysinate induced S-phase arrest and increased the anti-tumor activity of 5-FU in HeLa cells.
Lin YJ, Zhen YZ, Zhao YF, Wei J, Hu G.
Am J Chin Med. 2011;39(4):817-25.
Related citations
Microinvasive squamous carcinoma (FIGO stage IA1) of the cervix: are there colposcopic criteria for the diagnosis?
Furtado Y, Almeida G, Lima R, Silva K, Maldonado P.
Am J Obstet Gynecol. 2011 Oct;205(4):360.e1-4. Epub 2011 Jun 15.
First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers.
Jansen FH, Adoubi I, J C KC, DE Cnodder T, Jansen N, Tschulakow A, Efferth T.
Anticancer Res. 2011 Dec;31(12):4417-22.
Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
Shavit O, Raz R, Stein M, Chodick G, Schejter E, Ben-David Y, Cohen R, Arbel D, Shalev V.
Appl Health Econ Health Policy. 2012 Mar 1;10(2):87-97. doi: 10.2165/11594780-000000000-00000.
Editors' choice.
Berghella V, Bamfo J.
BJOG. 2011 Dec;118(13):i-ii. doi: 10.1111/j.1471-0528.2011.03214.x. No abstract available.
Regeneration of cervix after excisional treatment for cervical intraepithelial neoplasia: a study of collagen distribution.
Phadnis SV, Atilade A, Bowring J, Kyrgiou M, Young MP, Evans H, Paraskevaidis E, Walker P.
BJOG. 2011 Dec;118(13):1585-91. doi: 10.1111/j.1471-0528.2011.03085.x. Epub 2011 Sep 6.
Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.
Milrot E, Jackman A, Kniazhanski T, Gonen P, Flescher E, Sherman L.
Cancer Lett. 2012 Jun 1;319(1):31-8. Epub 2011 Dec 23.
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications.
Ferrandina G, Lucidi A, Paglia A, Corrado G, Macchia G, Tagliaferri L, Fanfani F, Morganti AG, Valentini V, Scambia G.
Eur J Surg Oncol. 2012 Mar;38(3):238-44. Epub 2011 Dec 24.
Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma.
Akita A, Shinmoto H, Hayashi S, Akita H, Fujii T, Mikami S, Tanimoto A, Kuribayashi S.
Eur Radiol. 2011 Sep;21(9):1850-7. Epub 2011 Apr 9.
Induction of Mitochondria-Mediated Apoptosis in Ca Ski Human Cervical Cancer Cells Triggered by Mollic Acid Arabinoside Isolated from Leea indica.
Wong YH, Abdul Kadir H.
Evid Based Complement Alternat Med. 2012;2012:684740. Epub 2011 Nov 20.
Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.
Nicol AF, Monsonego J.
Gynecol Oncol. 2011 Nov;123(2):179-81. No abstract available.
Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
Du XL, Tao J, Sheng XG, Lu CH, Yu H, Wang C, Song QQ, Li QS, Pan CX.
Gynecol Oncol. 2012 Apr;125(1):151-7. Epub 2011 Dec 22.
A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Rose PG, Sill MW, McMeekin DS, Ahmed A, Salani R, Yamada SD, Wolfson AH, Fusco N, Fracasso PM.
Gynecol Oncol. 2012 Apr;125(1):158-62. Epub 2011 Dec 22.
Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review.
Salem A, Salem AF, Al-Ibraheem A, Lataifeh I, Almousa A, Jaradat I.
Hematol Oncol Stem Cell Ther. 2011;4(4):173-81. doi: 10.5144/1658-3876.2011.173. Review.
Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study.
Singh H, Nugent Z, Demers AA, Bernstein CN.
Inflamm Bowel Dis. 2011 Aug;17(8):1741-50. doi: 10.1002/ibd.21567. Epub 2010 Nov 12.
Laparoscopic extraperitoneal para-aortic lymphadenectomy in the staging of locally advanced cervical cancer: is it a feasible procedure at a peripheral center?
Benito V, Lubrano A, Arencibia O, Andújar M, Pinar B, Medina N, Falcón JM, Falcón O.
Int J Gynecol Cancer. 2012 Feb;22(2):332-6.
Compliance with follow up cytology after discharge from the colposcopy clinic.
Khalid S, Carcopino X, Michail G, Metchette S, Conroy R, Prendiville W.
Ir Med J. 2011 Jun;104(6):167-70.
Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria.
Mbamara SU, Ikpeze OC, Okonkwo JE, Onyiaorah IV, Ukah CO.
J Reprod Med. 2011 Nov-Dec;56(11-12):491-6.
Reliability of magnetic resonance imaging for bladder or rectum invasion in cervical cancer.
Kim WY, Chang SJ, Chang KH, Yoo SC, Lee EJ, Ryu HS.
J Reprod Med. 2011 Nov-Dec;56(11-12):485-90.
Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP, Day ME, Dietrich CS 3rd, Tovar MM, Modesitt SC.
J Reprod Med. 2011 Sep-Oct;56(9-10):376-80.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on